KR100690071B1 - Functional composition for the prevention and improvement of hangover - Google Patents

Functional composition for the prevention and improvement of hangover Download PDF

Info

Publication number
KR100690071B1
KR100690071B1 KR1020050086889A KR20050086889A KR100690071B1 KR 100690071 B1 KR100690071 B1 KR 100690071B1 KR 1020050086889 A KR1020050086889 A KR 1020050086889A KR 20050086889 A KR20050086889 A KR 20050086889A KR 100690071 B1 KR100690071 B1 KR 100690071B1
Authority
KR
South Korea
Prior art keywords
extract
weight
hangover
vitamin
composition
Prior art date
Application number
KR1020050086889A
Other languages
Korean (ko)
Inventor
이승숙
김지훈
Original Assignee
주식회사 벤스랩
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 벤스랩 filed Critical 주식회사 벤스랩
Priority to KR1020050086889A priority Critical patent/KR100690071B1/en
Application granted granted Critical
Publication of KR100690071B1 publication Critical patent/KR100690071B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/334Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels

Abstract

A functional composition for preventing and improving hangover containing an extract of Milk thistle, aloe vera, epigallocatechin gallate(EGCG), pine needles, guava, vitamin C, Artemisia capillaris and Coriolus versicolor is provided. The composition exhibits excellent efficacy in reducing hangover in animal tests and thus can be used in prevention and improvement of hangover after drinking alcohol. The functional composition for preventing and improving hangover comprises: 20 to 40% by weight of aloe vera gel extract, 1 to 10% by weight of epigallocatechin gallate, 10 to 30% by weight of pine needle extract, 5 to 20% by weight of guava(Psidium guajava L.) leaf extract, 0.5 to 5% by weight of vitamin C, 0.5 to 5% by weight of vitamin B2, 5 to 20% by weight of Milk thistle(Silybum marianum) extract, 1 to 10% by weight of Artemisia capillaris extract and 1 to 15% by weight of Coriolus versicolor extract. The extract is obtained by extracting in water, lower alcohol such as ethanol, methanol, butanol or a mixed solvent(preferably methanol).

Description

숙취 예방 및 개선용 기능성 조성물{Functional composition for the prevention and improvement of hangover}Functional composition for hangover prevention and improvement

도 1은 본 발명의 기능성 조성물의 혈중 알코올 농도 감소 효과를 측정한 동물실험 결과도이고,1 is a result of animal experiments measuring the effect of reducing the blood alcohol concentration of the functional composition of the present invention,

도 2는 기능성 조성물의 숙취해소 효능에 대한 임상실험 결과도이다.Figure 2 is a clinical test result for the hangover efficacy of the functional composition.

본 발명은 음주로 인한 숙취를 해소시키는 효과를 갖는 기능성 조성물에 관한 것으로, 알로에베라겔, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C, 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 밀크티슬(Milk thistle) 추출물, 인진쑥 추출물 및 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물에 관한 것이다. The present invention relates to a functional composition having an effect of eliminating hangover caused by drinking, selected from the group consisting of aloe vera gel, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C, vitamin B 2 The present invention relates to a functional composition for preventing and improving hangover, comprising as a main ingredient a combination selected from the group consisting of milk thistle extract, jinjin wormwood extract, and fingering mushroom extract.

회식과 접대가 잦고 스트레스가 많은 현대인들에게 음주는 필수적인 것으로 자리잡고 있으며, 과다한 음주는 일시적으로 두근거림, 두통, 갈증, 멀미, 위장장애, 설사 등의 숙취현상(hangover)을 유발한다.Drinking is becoming essential for modern people who are frequent for dinner, entertainment and stress. Excessive drinking temporarily causes hangovers such as palpitations, headaches, thirst, motion sickness, stomach upset, and diarrhea.

따라서, 예전부터 에탄올의 독성을 경감시키거나 독성의 발현을 저해할 수 있는 많은 물질에 대한 연구와 실험이 진행되어 왔으며, 그 결과, 그와 관련된 천연식품이나 한약재료로부터 추출한 성분을 함유한 다양한 건강보조식품이 개발되고 있다(김정한 등, 한국농화학회지, 38(6), pp549-553, 1995).Therefore, researches and experiments have been conducted on many substances that can reduce the toxicity of ethanol or inhibit the expression of toxic substances. As a result, various health products containing ingredients extracted from related natural foods or herbal medicines have been conducted. Supplements are being developed (Kim Jung-han et al., Korean Journal of Agricultural Chemistry, 38 (6) , pp549-553, 1995).

최근 들어, 한약제 또는 민간요법제로서 숙취해소에 유용한 효과가 있다고 알려져 있는 인삼, 가시오가피 등의 성분을 주성분으로 하는 각종 제제 형태의 기능성 식품들이 개발되었다. 그 중 인삼을 주성분으로 하는 자양강장 드링크제가 다수 시판되고 있으며, 기타 꿀, 비타민 등의 각종 성분들도 적당량의 함량으로 조성하여 자양강장제로 시판되고 있다. 인삼, 가시오가피(Brekhman et al., Lloydia, 32(1), pp46-51, 1969), 오씨뭄(Ocimum sanctum Linn), 티노스포라말라바리카 (tinosporamalabarica)(Sen, P. et al., Indian J. Exp . Biol ., 30, pp592-596, 1992) 등의 생약과 멜라토닌 등의 생체물질이 숙취해소 작용을 나타낸다고 보고되어 있기는 하나, 음주에 의해 유발되는 다양한 숙취증상 중에서 일부 증상에만 효과가 있거나 숙취해소 효과가 미미한 것으로 나타났다. 얼마 전부터는 콩나물을 주원료한 식물 엑기스를 함유한 제품과 미배아와 대두 추출물을 함유한 제품이 소개되고 있다. 그러나, 이들 역시 제제의 안전성 면에서 여전히 해결해야 할 많은 문제점이 지적되었다. Recently, functional foods in the form of various preparations based on ingredients such as ginseng and thorny ginseng are known to have a beneficial effect on hangover as a herbal or folk remedy. Among them, a number of nourishing tonic drinks are mainly marketed as ginseng, and various ingredients such as honey and vitamins are also marketed as nourishing tonic. Ginseng, bramble (Brekhman et al ., Lloydia , 32 (1) , pp46-51, 1969), Ocimum sanctum Linn), tinosporamalabarica (Sen, P. et al., Indian J. Exp . Biol . , 30 , pp592-596, 1992) and biomaterials such as melatonin to hangover Although it has been reported to indicate, among the various hangover symptoms caused by drinking alcohol, it is effective only in some symptoms or has a small hangover effect. Recently, products containing plant extracts mainly containing soybean sprouts and products containing embryonic and soybean extracts have been introduced. However, they also point out a number of problems that still need to be addressed in terms of the safety of the formulation.

이와 같이 음주 후의 숙취제거를 위하여 각종 생약제를 포함하는 드링크제가 시판되고 있으나, 일부 생약제를 함유하는 드링크제는 전신권태, 복부팽만감, 구토 또는 복통 등을 유발하는 경우가 있을 뿐 아니라, 일부 드링크제는 고가의 생약제를 사용함으로써 고가로 판매되는 등의 문제점이 있다.As such, drink preparations containing various herbal medicines are commercially available for eliminating hangovers after drinking alcohol. However, drink preparations containing some herbal medicines may cause systemic boredom, bloating, vomiting or abdominal pain, and some drink preparations are expensive. There is a problem such as selling at high prices by using a herbal medicine.

이에 본 발명자들은 상기에서 서술한 바와 같이 현대인들의 음주에 대한 폐해를 동시에 해결하여 활기찬 일상생활을 유지할 수 있도록 하기 위하여 인체에 부작용이 없으면서 숙취 예방 및 개선할 수 있는 기능성 조성물을 개발하였다. Accordingly, the present inventors have developed a functional composition capable of preventing and improving hangovers without side effects in the human body in order to maintain the lively daily life by simultaneously solving the harmful effects of modern people drinking as described above.

따라서, 본 발명의 목적은 인체에 부작용이 없으면서 숙취 해소에 효과적인 조성물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a composition effective in relieving hangovers without any side effects on the human body.

상기 목적을 달성하기 위하여, 본 발명은 음주로 인한 숙취를 해소시키는 효과를 갖는 기능성 조성물을 제공한다. 보다 상세하게는 알로에베라겔, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C, 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 함유하는 숙취 예방 및 개선용 기능성 조성물을 제공한다. In order to achieve the above object, the present invention provides a functional composition having the effect of eliminating the hangover caused by drinking. More specifically, it provides a functional composition for preventing and improving hangover containing aloe vera gel, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C, and a combination selected from the group consisting of vitamin B 2 as a main ingredient. do.

상기 조성물은 알로에베라겔 추출물, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C 및 비타민 B2를 주성분으로 함유하는 숙취 예방 및 개선용 기능성 조성물을 포함한다. The composition includes a functional composition for preventing and improving hangover containing aloe vera gel extract, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C and vitamin B 2 as main ingredients.

또한, 상기 조성물에 밀크티슬(Milk thistle) 추출물, 인진쑥 추출물 및 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물을 제공한다.The present invention also provides a functional composition for preventing and improving hangover, which comprises a combination selected from the group consisting of milk thistle extract, jinjin wormwood extract, and fingerling mushroom extract as additional ingredients.

상기 조합은 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물인 기능성 조성물을 포함한다.The combination includes a functional composition which is a milk thistle extract, jinjin worm extract, fingerling mushroom extract.

상기 추출물은 물, 에탄올, 메탄올, 부탄올과 같은 저급 알콜 또는 이들의 혼합용매, 바람직하게는 메탄올에 가용한 추출물을 포함한다.The extracts include water, ethanol, methanol, lower alcohols such as butanol or mixtures thereof, preferably extracts soluble in methanol.

상기 주성분은 알로에베라겔 추출물 20 - 40 중량 %, 에피갈로카테킨갈레이트(EGCG) 1 - 10 중량 %, 솔잎추출물 10 - 30 중량 %, 구아바잎 추출물 5 - 20 중량 %, 비타민C 0.5 - 5 중량 %, 비타민B2 0.5 - 5 중량 %로 이루어진 것을 특징으로 한다.The main ingredient is 20-40% by weight of Aloe vera gel extract, 1-10% by weight of epigallocatechin gallate (EGCG), 10-30% by weight of pine needle extract, 5-20% by weight of guava leaf extract, 0.5-5% by weight of vitamin C. %, Vitamin B 2 It is characterized by consisting of 0.5 to 5% by weight.

상기 부가성분으로 포함되는 성분은 밀크티슬 추출물 5 - 20 중량 %, 인진쑥 추출물 1 - 10 중량 %, 운지버섯 추출물 1 - 15 중량 %로 이루어진 것을 특징으로 한다.Ingredients included as the additional component is characterized in that consisting of 5-20% by weight of milk Thistle extract, 1-10% by weight of the jinjin mugwort extract, 1-15% by weight fingering mushroom extract.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 알로에베라겔 추출물, 솔잎 추출물, 구아바잎 추출물, 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물은 하기와 같이 수득될 수 있다.Aloe vera gel extract, pine needle extract, guava leaf extract, milk Thistle extract, jinjin worm extract, fingerling mushroom extract of the present invention can be obtained as follows.

먼저, 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인진쑥, 운지버섯을 각각 건조 후 마쇄하여 분말화 한 후, 각 건조 중량의 약 2 내지 20 배, 바람직하게는 약 3 내지 7 배에 달하는 부피의 물, 메탄올, 에탄올 및 부탄올과 같은 저급 알콜 또는 이들의 약 1:0.1 내지 1:10의 혼합비를 갖는 혼합용매, 바람직하게는 물로 20 내지 100 ℃, 바람직하게는 60 내지 80 ℃의 추출 온도에서 약 0.5시간 내지 2일, 바람직하게는 1 시간 내지 1일 동안 일정시간 간격으로, 열수 추출, 냉침 추출, 환류 냉각 추출 또는 초음파 추출 등의 추출방법, 바람직하게는 열수 추출로 1회 내지 5회, 바람직하게는 3회 연속 추출하여 감압여과하고 여과추출물을 진공회전농축기로 20 내지 100 ℃, 바람직하게는 20 내지 70 ℃에서 감압농축하여 물, 저급알콜 또는 이들의 혼합용매에 가용한 각 추출물을 수득할 수 있다.First, aloe vera gel, pine needles, guava leaf, milk thistle, phosphorus mugwort, and fingerling mushrooms are dried and pulverized, respectively, and then powdered, and then each volume is about 2 to 20 times, preferably about 3 to 7 times the dry weight. Lower alcohols such as water, methanol, ethanol and butanol, or mixed solvents having a mixing ratio of about 1: 0.1 to 1:10, preferably about 20 to 100 ° C, preferably about 60 to 80 ° C, with an extraction temperature of about 0.5 hours to 2 days, preferably 1 hour to 1 day at a predetermined time interval, extraction method such as hot water extraction, cold extraction, reflux cooling extraction or ultrasonic extraction, preferably 1 to 5 times by hot water extraction, preferably Preferably, the extract is filtered three times under reduced pressure, and the filtrate is concentrated under reduced pressure at 20 to 100 ° C., preferably at 20 to 70 ° C., using a vacuum rotary concentrator to extract water, lower alcohol, or a mixed solvent thereof. Can be obtained.

또한, 본 발명은 상기 방법으로 수득한 알로에베라겔 추출물, 솔잎 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 외에 기타 식품 성분을 함유하는 식품을 제공한다.In addition, the present invention, the aloe vera gel extract, pine needle extract and epigallocatechin gallate (EGCG), guava leaf extract, vitamin C and vitamin B 2 obtained by the above method as a main component, the method It provides a food containing other food ingredients in addition to the functional composition for preventing and improving a hangover comprising a combination selected from the group consisting of milk thistle extract, phosphorus mugwort extract, finger finger mushroom extract obtained as an additional ingredient.

상기 식품은 과자류, 당류, 아이스크림 제품류, 유가공품, 식육제품, 어육제품, 두부류 또는 묵류, 식용유지류, 면류, 다류, 음료류, 특수영양식품, 건강보조식품, 조미식품, 얼음, 인삼제품류, 김치절임식품, 건포류 외 기타 식품류를 포함한다.The food is confectionary, sugar, ice cream products, dairy products, meat products, fish meat products, tofu or jelly, edible oils and fats, noodles, teas, beverages, special nutrition products, health supplements, seasoned foods, ice, ginseng products, pickles And raisins and other foodstuffs.

한편, 상기 식품의 형태는 분말, 과립, 정제, 캡슐, 액상 또는 음료 형태를 포함한다.Meanwhile, the form of the food includes powder, granule, tablet, capsule, liquid or beverage form.

또한, 본 발명은 알로에베라겔 추출물, 솔이 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 식품첨가제를 제공한다.In addition, the present invention is a milk tease obtained by the aloe vera gel extract, a sol extract and epigallocatechin gallate (EGCG), guava leaf extract, a combination selected from the group consisting of vitamin C and vitamin B 2 as a main ingredient, It provides a functional composition food additive for preventing and improving a hangover comprising a combination selected from the group consisting of extracts, jinjin wormwood extract, finger finger mushroom extract as an additional ingredient.

상기 식품첨가제는 분말, 과립, 정제, 캡슐, 액상 또는 음료 형태를 포함한다.The food additives include powders, granules, tablets, capsules, liquid or beverage forms.

또한, 본 발명은 상기의 식품첨가제를 식품에 살균제, 향신료, 조미제, 여러가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등 또는 식품소재의 필수원료로 사용하는 것을 특징으로 하는 식품첨가제의 이용방법을 제공한다. 이때 식품첨가제는 식품을 침지, 분무 또는 혼합하여 상기 식품에 첨가할 수 있으며, 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다.In addition, the present invention, the food additives in the food, such as fungicides, spices, seasonings, various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, such as colorants and neutralizing agents (cheese, chocolate, etc.) ), Pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, or the like as essential raw materials for food materials It provides a method of using a food additive characterized in that. In this case, the food additive may be added to the food by dipping, spraying or mixing the food, and the ratio of such additive is not so important, but it is generally selected from 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention. .

식품은 과일, 야채, 과일이나 야채의 건조제품이나 절단제품, 과일쥬스, 야채쥬스, 이들의 혼합쥬스이거나 칩류, 면류, 축산가공식품, 수산가공식품, 유가공식품, 발 효유식품, 두류식품, 곡류식품, 미생물발효식품, 제과제빵, 양념류, 육가공류, 산성음료수, 감초류, 허브류 중 어느 하나 또는 하나 이상이다.Foods are fruits, vegetables, dried or cut products of fruits or vegetables, fruit juices, vegetable juices, mixed juices of these, chips, noodles, livestock processed foods, fish processed foods, dairy products, fermented milk foods, legumes food, cereals One or more of food, microbial fermented food, bakery, condiments, meat processing, acidic beverages, licorice, herbs.

또한, 본 발명은 알로에베라겔 추출물, 솔잎 추출물과 에피갈로카테킨갈레이트(EGCG), 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 상기 방법으로 수득한 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물로 이루어진 군으로부터 선택된 조합을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물 외에 식품학적으로 허용가능한 식품보조첨가제를 포함하는 건강기능식품을 제공한다.The present invention also comprises aloe vera gel extract, pine needle extract and epigallocatechin gallate (EGCG), guava leaf extract, vitamin C and vitamin B 2 , the milk ingredient obtained by the above method as a main ingredient It provides a health functional food comprising a food supplement acceptable food supplements in addition to the functional composition for preventing and improving a hangover comprising as an additional ingredient a combination selected from the group consisting of extracts, Injin mugwort extract, fingerling mushroom extract.

상기 건강기능식품은 분말, 과립, 정제, 캡슐 또는 음료 형태인 건강기능식품을 포함한다.The dietary supplement includes a dietary supplement in the form of a powder, granule, tablet, capsule or beverage.

본 발명은 숙취 예방 및 개선 효과를 나타내는 상기 조성물 및 식품학적으로 허용 가능한 식품보조 첨가제를 포함하는 건강기능식품을 제공한다. 상기 조성물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강기능 식품류 등이 있다. The present invention provides a health functional food comprising the composition and a food acceptable food supplement additive exhibiting a hangover prevention and improvement effect. Examples of the food to which the composition can be added include various foods, beverages, gums, teas, vitamin complexes, and health functional foods.

또한, 숙취 예방 및 개선을 목적으로 식품 또는 음료에 첨가될 수 있다. 이 때, 식품 또는 음료 중의 상기 조성물의 양은, 일반적으로 본 발명의 건강기능식품 조성물의 경우는 전체 식품 중량의 0.01 내지 15 중량 %, 바람직하게는 0.1 내지 10 중량 %로 가할 수 있으며, 건강 음료 조성물에는 100 ㎖를 기준으로 0.01 ~ 15 g, 바람직하게는 0.1 ~10 g의 비율로 가할 수 있다. It may also be added to food or beverages for the purpose of preventing and improving hangovers. At this time, the amount of the composition in the food or beverage, in general, in the case of the nutraceutical composition of the present invention can be added to 0.01 to 15% by weight, preferably 0.1 to 10% by weight of the total food weight, the health beverage composition It can be added at a ratio of 0.01 to 15 g, preferably 0.1 to 10 g based on 100 ml.

본 발명의 건강 음료 조성물은 지시된 비율로 필수 성분으로서 상기 조성물을 함유하는 외에 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리스리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등), 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖ 당 일반적으로 약 1 ~ 20 g, 바람직하게는 약 5 ~ 12 g이다.The health beverage composition of the present invention, in addition to containing the composition as an essential ingredient in the indicated ratio, is not particularly limited in the liquid component and may contain various flavors or natural carbohydrates, etc. as additional ingredients, as in general beverages. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.), and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. The ratio of said natural carbohydrate is generally about 1-20 g, preferably about 5-12 g per 100 ml of the composition of the present invention.

상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 조성물들은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다. In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. The compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.

본 발명의 조성물에는 구연산, 후말산, 아디픽산, 젖산, 사과산 등의 유기산이나 인산나트륨, 인산칼륨, 산성피로인산염, 폴리인산염(중합인산염) 등의 인산염이나 폴리페놀, 카테킨(catechin), 알파-토코페롤, 로즈메리 추출물(rose mary extract), 감초 추출물, 키토산, 탄닌산, 피틴산 등의 천연 항산화제 중 어느 하나 또는 하나 이상을 추가로 포함할 수 있다.The composition of the present invention includes organic acids such as citric acid, fumaric acid, adipic acid, lactic acid and malic acid, phosphates such as sodium phosphate, potassium phosphate, acid pyrophosphate and polyphosphate (polyphosphate), polyphenols, catechins and alpha- It may further include any one or more of natural antioxidants such as tocopherol, rose mary extract, licorice extract, chitosan, tannic acid, phytic acid.

상기의 조성물은 20 내지 90 % 고농축액이거나 분말이거나 과립형태일 수 있다.The composition may be 20 to 90% high concentrate, powder or granule form.

마찬가지로, 본 발명의 조성물은 유당 카제인, 덱스트린, 포도당, 설탕, 솔비톨 중 어느 하나 또는 하나 이상을 추가로 포함할 수 있다.Likewise, the composition of the present invention may further comprise any one or more of lactose casein, dextrin, glucose, sugar, sorbitol.

이하, 본 발명을 실시예 및 실험예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail by Examples and Experimental Examples.

단, 하기 실시예 및 실험예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예 및 실험예에 의해 한정되는 것은 아니다.However, the following Examples and Experimental Examples are merely illustrative of the present invention, and the content of the present invention is not limited by the following Examples and Experimental Examples.

실시예Example 1. 추출물의 제조 1. Preparation of Extract

본 발명에 사용한 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인진쑥, 운지버섯은 상점 및 경동시장에서 구입하여 사용하였다. 알로에베라겔, 솔잎, 구아바잎, 밀크티슬, 인지쑥, 운지버섯를 각각 1 kg을 건조 후 마쇄하여 얻은 분말 각 300 내지 600 g을 집기병에 담은 후 증류수 2 ℓ를 넣고 70 ℃에서 일정시간 간격(12 h, 6h, 3h)으로 3회 반복하여 열수 추출한 후, 여지(와트만사, 미국)로 감압여과한 다음, 여과 추출물은 진공회전농축기로 40 ℃에서 증류수를 제거한 후 추출된 잔사로써 각 추출물 50 내지 200 g을 수득하였다. Aloe vera gel, pine needles, guava leaf, milk thistle, jinjin wormwood, and fingering mushrooms used in the present invention were used in stores and Gyeongdong market. After drying 1 kg of aloe vera gel, pine needles, guava leaf, milk thistle, ginko wormwood, and fingering mushrooms, each 300 to 600 g of powder obtained by grinding and crushing was put in a household jar, and 2 liters of distilled water was added at a predetermined time interval (12 h , 6h, 3h) was extracted three times with hot water, filtered under reduced pressure with a filter paper (Watman, USA), and then the filtrate extract was extracted with distilled water at 40 ° C. with a vacuum rotary concentrator. g was obtained.

각 후보물질 농축액은 4℃보관 농축시료로서 혹은 디스크타입 분무건조(spray dryer), 또는 동결건조(freezing dryer)를 이용하여 분말형태로 준비하여 시료로 준비할 수 있으며 건조된 분말시료는 수분흡수를 억제된 상태로 보관하였다.Each candidate concentrate can be prepared as a sample using a concentrated sample stored at 4 ° C, or in the form of a powder using a disk-type spray dryer or freezing dryer. Stored in a restrained state.

실시예Example 2. 기능성 조성물의 제조 2. Preparation of Functional Composition

상기 실시예 1에서 수득한 알로에베라겔 추출물 20 - 40 중량 %, 솔잎 추출물 10 - 30 중량 %과 에피갈로카테킨갈레이트(EGCG) 1 - 10 중량 %, 구아바잎 추출물 5 - 20 중량 %, 비타민 C 0.5 - 5 중량 % 및 비타민 B2 0.5 -5 중량 %를 주성분으로 하고, 상기 실시예 1에서 수득한 밀크티슬 추출물 5 - 20 중량 %, 인진쑥 추출물 1 - 10 중량 %, 운지버섯 추출물 1 - 15 중량 % 를 부가성분으로 하고 이를 혼합하여 기능성 조성물을 제조하였다.Aloe vera gel extract obtained in Example 1 20-40% by weight, pine needle extract 10-30% by weight and epigallocatechin gallate (EGCG) 1-10% by weight, guava leaf extract 5-20% by weight, vitamin C 0.5-5% by weight and 0.5-5% by weight of vitamin B 2 as a main ingredient, 5-20% by weight of the milk thistle extract obtained in Example 1, 1-10% by weight of the Mugwort extract, 1-15% by fingerling mushroom extract A functional composition was prepared by adding% as an additive ingredient and mixing them.

실험예Experimental Example 1.  One. 천연물질군에서In the natural substance group 알코올 분해효소( Alcohol degrading enzymes ( ADHADH ) 및 아세트알데히드 분해효소() And acetaldehyde degrading enzyme ( ALDHALDH )활성측정Activity measurement

1-1. 실험 방법1-1. Experiment method

천연물질이 숙취해소 효능이 있는지를 탐색하기 위하여 숙취해소 효능에 가장 중요한 인자인 ADH와 ALDH의 활성을 시험관 내(in vitro)에서 측정하였다.Within the natural substance is the most important factor in vitro ADH and ALDH activity of the hangover effects to search whether there is a hangover effect (in in vitro ).

효소는 동결건조된 S9 rat liver homogenate (MOLTOX Co., USA)를 0.1% 소 혈청 알부민 (bovine serum albumin) 용액 8 ml에 녹여 0.45 ㎛ 주사 필터(syringe filter)로 여과한 후 사용하였다.The enzyme was used after dissolving lyophilized S9 rat liver homogenate (MOLTOX Co., USA) in 8 ml of 0.1% bovine serum albumin solution and filtering it with a 0.45 μm injection filter.

ADH의 활성측정은 흡광도 340nm에서 NADH의 생성속도를 지표로 사용하였으며, 반응 액의 조성은 증류수 1.4 ml, 1.0 M 트리스-HCl 완충액(tris-HCl buffer)(pH 8.8) 0.75 ml, 20 mM NAD+ 0.3 ml, 에탄올(ethanol) 0.3 ml, 시료(sample) 0.1 ml의 혼합액과 효소 0.15 ml를 큐벳에 넣어 총 3ml이 되도록 하였다. 시료를 30℃에서 5분간 전처리 한 후, 340nm에서 5분 동안 흡광도 변화를 측정하였다. 이때, 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ADH활성은 대조군에 대한 상대활성(%)으로서 측정하였다.The activity of ADH was measured by the rate of NADH production at the absorbance of 340 nm. The composition of the reaction solution was 1.4 ml of distilled water, 0.75 ml of 1.0 M tris-HCl buffer (pH 8.8), 20 mM NAD + 0.3 ml, 0.3 ml of ethanol, 0.1 ml of sample, and 0.15 ml of enzyme were put in a cuvette to make a total of 3 ml. After the sample was pretreated at 30 ° C. for 5 minutes, the absorbance change was measured at 340 nm for 5 minutes. At this time, the sample was not added as a control, the ADH activity of the sample was measured as relative activity (%) relative to the control.

ALDH의 활성측정은 흡광도 340nm에서 NADH의 생성속도를 지표로 사용하였으며, 반응액의 조성은 증류수 2.1 ml, 1.0 M 트리스-HCl 완충액(pH 8.0) 0.3 ml, 20 mM NAD+ 0.1 ml, 1.0 M 아세탈디하이드(acetaldehyde) 0.1 ml, 3.0 M KCl 0.1 ml, 0.33 M 2-메르캅토에탄올(mercaptoethanol) 0.1 ml, 시료 0.1 ml의 혼합액과 효소 0.1 ml를 큐벳에 넣어 총 3ml이 되도록 하였다. 시료를 30℃에서 5분간 전처리 한 후, 340nm에서 5분 동안 흡광도 변화를 측정하였다. 이때, 시료를 첨가하지 않은 것을 대조군으로 하였으며, 시료의 ALDH활성은 대조군에 대한 상대활성(%)으로서 측정하였다.The activity of ALDH was measured by the rate of NADH production at the absorbance of 340 nm. The composition of the reaction solution was 2.1 ml of distilled water, 0.3 ml of 1.0 M Tris-HCl buffer (pH 8.0), 20 mM NAD + 0.1 ml, 1.0 M acetal. 0.1 ml of dialdehyde (acetaldehyde), 0.1 ml of 3.0 M KCl, 0.1 ml of 0.33 M 2-mercaptoethanol, 0.1 ml of the sample, and 0.1 ml of enzyme were put in a cuvette to make a total of 3 ml. After the sample was pretreated at 30 ° C. for 5 minutes, the absorbance change was measured at 340 nm for 5 minutes. At this time, the sample was not added as a control, the ALDH activity of the sample was measured as relative activity (%) relative to the control.

1-2. 1-2. ADHADH Wow ALDHALDH 활성도 측정 결과  Activity measurement result (( inin vitroin vitro ))

표 1은 각 식물추출물 100ppm에서의 ADH와 ALDH의 활성을 나타낸 것으로 ADH의 활성은 알로에 베라겔 추출물 118.5%, 구아바잎 추출물 114.3%, 솔잎 추출물 113.4%, 밀크티슬 추출물 107.3% 등의 순으로 나타났으며, ALDH의 활성은 전체적으로 ADH에 비하여 효소활성의 차이가 뚜렷하게 나타나지 않았다. 전체시료 가운데에서 알로에베라겔 추출물과 구아바잎 추출물이 ADH와 ALDH에서 모두 높은 효소활성을 나타내어 생체 내(in vivo) 실험에서 활성이 기대된다.Table 1 shows the activities of ADH and ALDH at 100 ppm of each plant extract. The activity of ADH was 118.5% in aloe vera gel extract, 114.3% in guava leaf extract, 113.4% in pine needle extract, and 107.3% in milk tease extract. , ALDH activity showed no significant difference in enzyme activity compared to ADH. It represented the entire sample of beragel aloe extract and guava leaf extract is high in both ADH and ALDH enzyme activity in vivo (in In vivo ) activity is expected.

NoNo 시료sample ADH 활성 (%)ADH activity (%) ALDH 활성 (%)ALDH Activity (%) 1One 알로에베라겔 추출물Aloe Vera Gel Extract 118.5118.5 98.698.6 22 구아바잎 추출물Guava Leaf Extract 114.3114.3 98.498.4 33 솔잎 추출물Pine Needle Extract 113.4113.4 97.597.5 44 밀크티슬 추출물Milk Thistle Extract 107.3107.3 99.399.3 55 인진쑥 추출물Mugwort Extract 104.1104.1 96.596.5 66 운지버섯 추출물Fingering Mushroom Extract 102.3102.3 96.796.7

실험예Experimental Example 2. 동물실험 2. Animal experiment

2-1. 숙취해소 후보물질 투여에 따른 혈중알코올 농도 감소효과 측정2-1. Measurement of Blood Alcohol Concentration Effect by Hangover Candidate Remedy

상기 시험관내(in vitro) 실험에서 수행한 숙취해소 물질을 대상으로 동물실험을 수행하였다. 동물실험은 평균 체중 30g의 흰쥐(ICR mouse) 10마리를 한 개의 실험군으로 하여 각 농도의 후보물질을 0.2 ml의 양으로 경구투여용 주사기로 구강 내에 직접 투여하고 대조군은 같은 양의 물을 경구투여 하였다. The in vitro ( in In vitro ) animal experiments were performed on the hangover-resolved substances. Animal experiments consisted of 10 rats (ICR mouse) with an average body weight of 30 g as one experimental group, and the candidate substance of each concentration was administered directly into the oral cavity with an oral syringe in an amount of 0.2 ml, and the control group was orally administered with the same amount of water. It was.

시료를 투여한지 10분이 지난 후 40% 에탄올을 0.2 ml의 양으로 경구투여하고, 그로부터 45분 및 90분 경과시 혈액을 미정맥에서 20 ㎕ 씩을 채취하여 EDTA-처리한 수기에 받은 후 즉시 6.25%의 TCA용액 180 ㎕을 가하여 2000rpm에서 10분간 원심분리하였다. 상등액 20 ㎕를 취하여 시그마사의 NAD-ADH 효소액 (Sigma-Aldrich사) 0.5 ml에 각각 넣고 이를 37℃에서 10분간 정치시킨 후 340nm에서 흡광도를 측정하였다. 이후, 에탄올 표준물질(0.05 %, 0.1 %, 0.3 %(w/v))을 이용한 에탄올 표준 셋트(ethanol standard set, Sigma kit)로 각 실험군의 혈중알코올 농도를 계산하였다.(표 2)10 minutes after the administration of the sample, 40% ethanol was orally administered in an amount of 0.2 ml, and at 45 and 90 minutes thereafter, 20 μl of blood was collected from the microvein and received in an EDTA-treated hand. 180 μl of TCA solution was added and centrifuged at 2000 rpm for 10 minutes. 20 μl of the supernatant was added to 0.5 ml of Sigma's NAD-ADH enzyme solution (Sigma-Aldrich, Inc.), respectively, which was allowed to stand at 37 ° C. for 10 minutes, and the absorbance was measured at 340 nm. Thereafter, the blood alcohol concentration of each experimental group was calculated using an ethanol standard set (Sigma kit) using ethanol standards (0.05%, 0.1%, 0.3% (w / v)) (Table 2).

숙취해소 후보물질 투여에 따른 혈중알코올 농도 감소효과 측정결과Blood alcohol concentration reduction effect by hangover candidate 혈중 알코올농도 (%)Blood alcohol level (%) 45분45 minutes 90분90 minutes 대조군Control 0.1320.132 0.0810.081 알로에베라겔 추출물Aloe Vera Gel Extract 0.1030.103 0.0640.064 구아바잎 추출물Guava Leaf Extract 0.1110.111 0.0660.066 솔잎 추출물Pine Needle Extract 0.1200.120 0.0700.070 밀크티슬 추출물Milk Thistle Extract 0.1240.124 0.0640.064 인진쑥 추출물Mugwort Extract 0.1240.124 0.0730.073 운지버섯 추출물Fingering Mushroom Extract 0.1200.120 0.0710.071

상기 표 2의 결과로부터 알 수 있듯이, 숙취해소 물질의 마우스를 대상으로 한 동물실험에서 혈중알콜농도 감소효과를 측정한 결과 시험관 내(in vitro) 실험결과와 유의하게 혈중알콜농도 감소효과를 나타내었다. As can be seen from the results of Table 2, the results of measuring the blood alcohol concentration reduction in the animal experiments on mice with hangover-relieving substances in vitro ( in In vitro ) and blood alcohol concentration significantly decreased.

2-2. 숙취해소 효능에 대한 동물 실험2-2. Animal Experiments on Hangover Relief

숙취 해소 효능을 알아보기 위해, 실시예 2의 기능성 조성물을 마우스에 1 g/kg의 양으로 하여 평균 체중 30 g의 ICR 마우스(6주령)의 구강 내에 직접 투여하였다. 이 때 마우스 10마리를 한 개의 실험군으로 하였으며, 대조군에는 동일한 양의 물을 투여하였다. 시료를 투여한 지 10분이 경과 후, 40 % 에탄올 0.2 ㎖를 마우스에 경구 투여하였으며, 45분 및 90분 경과 후 미정맥에서 혈액 20 ㎕ 씩을 채취하여 EDTA-처리한 수기에 받은 후, 즉시 6.25 %의 TCA 용액 180 ㎕을 가하여 2000 rpm에서 10분간 원심분리하였다. 상등액 20 ㎕를 취하여 NAD-ADH 효소액(Sigma사) 0.5 ㎖에 넣고 이를 37 ℃에서 10분간 정치시킨 후, 340 nm에서 흡광도를 측정하였다. 이후, 에탄올 표준물질(0.05 %, 0.1 %, 0.3 %(w/v))을 이용한 에탄올 표준 셋트(ethanol standard set, Sigma kit)로 각 실험군의 혈중 알코올 농도를 계산하였다.In order to determine the hangover efficacy, the functional composition of Example 2 was administered directly to the oral cavity of an average weight 30 g of ICR mice (6 weeks old) in mice at an amount of 1 g / kg. At this time, 10 mice were used as one experimental group, and the control group was administered with the same amount of water. Ten minutes after the administration of the sample, 0.2 ml of 40% ethanol was orally administered to the mice. After 45 and 90 minutes, 20 μl of blood was collected from the caudate vein and received in an EDTA-treated hand. 180 μl of TCA solution was added and centrifuged at 2000 rpm for 10 minutes. 20 μl of the supernatant was added to 0.5 ml of NAD-ADH enzyme solution (Sigma), which was allowed to stand at 37 ° C. for 10 minutes, and the absorbance was measured at 340 nm. Then, the blood alcohol concentration of each experimental group was calculated with an ethanol standard set (Sigma kit) using ethanol standards (0.05%, 0.1%, 0.3% (w / v)).

그 결과, 도 1에 알 수 있는 것처럼, 시료를 투여한 지 45분 경과 후 대조군의 혈 중 알코올 농도는 0.13 % 인 반면, 기능성 조성물을 투여한 실험군의 혈 중 알코올 농도는 0.09 % 였으며, 90분 경과 후 대조군의 혈 중 알코올 농도는 0.08 %인 반면, 기능성 조성물을 투여한 실험군의 혈 중 알코올 농도는 0.04 %로 감소하였다. 따라서, 대조군에 비하여 본 발명의 기능성 조성물의 그 숙취해소 효능이 훨씬 탁월함이 확인되었다.As a result, as shown in Figure 1, 45 minutes after the administration of the sample, the blood alcohol concentration of the control group was 0.13%, whereas the blood alcohol concentration of the experimental group administered the functional composition was 0.09%, 90 minutes Afterwards, the blood alcohol concentration of the control group was 0.08%, whereas the blood alcohol concentration of the experimental group to which the functional composition was administered decreased to 0.04%. Accordingly, it was confirmed that the hangover efficacy of the functional composition of the present invention was much superior to the control group.

실험예Experimental Example 3. 숙취해소 기능성 조성물의  3. Hangover Relief of Functional Composition 급성독성Acute Toxicity 실험 Experiment

본 숙취해소 기능성 조성물의 안전성 실험을 위해 단회경구투여 급성독성 실험을 수행하였다. 실험동물은 쥐(Sprague Dawley outbred rats)를 사용하였으며, 암컷 5마리, 수컷 5마리는 실험군으로, 암컷 1마리, 수컷 1마리는 대조군으로 사용하였다. 기능성 조성물을 경구투여하기 전 12시간동안 사료를 금식시켰으나, 물은 충분히 공급하였다. 기능성 조성물은 쥐(SD rat) 체중 1kg 당 5g 되게 투여하였다. 기능성 조성물을 투여한 후 사료는 정상적으로 공급하였으며, 14일 동안 육안으로 쥐(rat)의 행동과 이상 징후를 관찰하였다.(표 3 및 표 4)    For the safety test of the hangover functional composition, a single oral dose acute toxicity test was performed. Sprague Dawley outbred rats were used as experimental animals. Five females and five males were used as experimental groups, and one female and one male were used as controls. The food was fasted for 12 hours prior to oral administration of the functional composition, but with sufficient water. The functional composition was administered at 5 g / kg of rat rat body weight. The feed was normally supplied after administration of the functional composition, and rat behavior and abnormal signs were visually observed for 14 days (Tables 3 and 4).

안전성(급성독성) 실험결과Safety (Acute Toxicity) Test Results No No 항목 Item 성별 gender 일(Day)Day 1One 22 33 44 55 66 77 88 99 1010 1111 1212 1313 1414 1One 실험군Experimental group MM 0*0* 00 00 00 00 00 00 00 00 00 00 00 00 00 22 실험군Experimental group MM 00 00 00 00 00 00 00 00 00 00 00 00 00 00 33 실험군Experimental group MM 00 00 00 00 00 00 00 00 00 00 00 00 00 00 44 실험군Experimental group MM 00 00 00 00 00 00 00 00 00 00 00 00 00 00 55 실험군Experimental group MM 00 00 00 00 00 00 00 00 00 00 00 00 00 00 66 대조군Control MM 00 00 00 00 00 00 00 00 00 00 00 00 00 00 77 실험군Experimental group FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 88 실험군Experimental group FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 99 실험군Experimental group FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 1010 실험군Experimental group FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 1111 실험군Experimental group FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 1212 대조군Control FF 00 00 00 00 00 00 00 00 00 00 00 00 00 00 M : 수컷 F : 암컷 0* = 독성 증상 없음 M: Male F: Female 0 * = no toxic symptoms

기능성 조성물 투여 후 SD 쥐(rat)의 체중변화 Weight Change in SD Rats after Functional Composition Administration 체중 (g)Body weight (g) 1일1 day 7일7 days 14일14 days 1One 실험군Experimental group MM 278278 293293 334334 22 실험군Experimental group MM 269269 275275 315315 33 실험군Experimental group MM 284284 308308 347347 44 실험군Experimental group MM 280280 284284 321321 55 실험군Experimental group MM 272272 263263 315315 66 대조군Control MM 279279 301301 330330 77 실험군Experimental group FF 208208 219219 231231 88 실험군Experimental group FF 203203 217217 227227 99 실험군Experimental group FF 203203 224224 233233 1010 실험군Experimental group FF 213213 221221 227227 1111 실험군Experimental group FF 201201 212212 221221 1212 대조군Control FF 205205 212212 220220 M : 수컷 F : 암컷   M: Male F: Female

급성독성 실험결과는 상기 표 3, 표 4와 같이 숙취해소 물질 투여 후 사망은 보이지 않았고, 육안 관찰시 건강상태는 양호하였으며, 체중도 정상적이었다. 14일 후 해부시 육안 검사결과 각 조직기관에 어떠한 이상도 나타나지 않았으므로 기능성 조성물이 안전하다는 것을 알 수 있었다.    As a result of the acute toxicity test, as shown in Table 3 and Table 4, there was no death after the hangover administration, and the visual condition was good and the body weight was normal. 14 days later, the dissection showed that the functional composition was safe because no abnormalities were observed in each tissue.

실험예Experimental Example 4. 숙취해소 효능에 대한 임상실험 4. Clinical trial on hangover relief

상기 실시예 2에서 제조한 기능성 조성물의 숙취해소 효능을 측정하기 위하여, 건강한 20-30대 성인남녀 40명(표 5참조)을 대상으로 하기와 같은 방법으로 3회에 걸쳐 실험하여 평균값을 계산하였다. 먼저 15분간 소주 반병(알콜도수 22도, 참이슬, 한국) 180 ㎖와 쏘시지 3조각을 섭취하고, 10분 후 실험군에는 상기 실시예 2의 기능성 조성물 100 ㎖(1% 농도)와 대조군에는 동일한 부피의 위약(생수)을 복용하게 한 다음, 섭취가 끝난 후 30분 및 2시간 후에 정맥 채혈을 수행하여 혈중 알코올농도를 측정하였다. 또한, 자각증상을 평가하기 위하여 알코올 섭취 후 30분, 1시간, 3시간, 5시간 경과한 시점에서 설문조사 수행하였다.In order to measure the hangover efficacy of the functional composition prepared in Example 2, 40 healthy males and females in their 20s and 30s (see Table 5) were tested three times in the following manner to calculate the average value. . First, take a half bottle of soju (alcohol number 22 degrees, Chamomile, Korea) for 15 minutes and three pieces of sausage, and after 10 minutes, 100 ml (1% concentration) of the functional composition of Example 2 in the experimental group and the same volume in the control group After taking the placebo (bottled water), the blood alcohol concentration was measured by intravenous blood collection 30 minutes and 2 hours after the end of intake. In addition, the survey was conducted at 30 minutes, 1 hour, 3 hours, 5 hours after alcohol intake to evaluate subjective symptoms.

연령(년)Age (years) 27.56 ± 5.0427.56 ± 5.04 성별 (남:여)Gender Male Female) 3:13: 1 체중(kg)Weight (kg) 68.34 ± 9.1568.34 ± 9.15

그 결과, 도 2에서 나타낸 바와 같이, 각 시료 섭취 30 분 후 대조군의 혈중 알코올 농도는 0.09 % 였고, 기능성 조성물을 섭취한 실험군의 혈중 알코올 농도는 0.08 % 였다. 섭취 120 분 후, 대조군의 혈중 알코올 농도는 0.07 % 인 반면, 기능성 조성물을 섭취한 실험군의 혈중 알코올 농도는 0.02 %로 급격히 감소하였다. 따라서, 기능성 조성물이 대조군에 비해 뚜렷한 숙취해소 효과를 나타냄을 확인할 수 있었다.As a result, as shown in FIG. 2, the blood alcohol concentration of the control group was 0.09% after 30 minutes of ingestion of each sample, and the blood alcohol concentration of the experimental group ingesting the functional composition was 0.08%. After 120 minutes of ingestion, the blood alcohol concentration of the control group was 0.07%, while the blood alcohol concentration of the experimental group ingesting the functional composition decreased to 0.02%. Therefore, it was confirmed that the functional composition showed a clear hangover effect compared to the control.

또한, 설문조사 결과 기능성 조성물이 확실한 숙취해소 효능을 가지고 있음을 알 수 있었다. 설문조사 결과는 표 6과 같다.In addition, the survey showed that the functional composition has a clear hangover efficacy. The survey results are shown in Table 6.

자각증상 평가 설문조사 결과Subjective Symptom Assessment Results (1: 효과없음, 3: 중간, 5: 효과높음)                             (1: no effect, 3: medium, 5: high effect) 항목Item 갈증thirst 졸음drowsiness 두통headache 어지러움whirl 오심/구토Nausea / vomiting 무력감Helplessness 집중곤란Concentration 기능성 조성물 (실험군)Functional composition (experimental group) 4.144.14 4.514.51 4.334.33 4.184.18 4.254.25 4.044.04 4.434.43 위약 (대조군)Placebo (Control) 3.213.21 3.023.02 2.982.98 3.113.11 2.852.85 3.133.13 3.143.14

제제예Formulation example 1. 건강 식품의 제조 1. Manufacture of healthy food

실시예 2의 기능성 조성물......................1000 ㎎Functional composition of Example 2 ... 1000 mg

비타민 혼합물..................................20 gVitamin Blend ......................... 20 g

비타민 A 아세테이트............................70 ㎍Vitamin A Acetate ............... 70 μg

비타민 E......................................1.0 ㎎Vitamin E ...................................... 1.0 mg

비타민 B1..........................................................0.13 ㎎Vitamin B 1 ...... ........... 0.13 mg

비타민 B2..........................................................0.15 ㎎Vitamin B 2 ...... ........... 0.15 mg

비타민 B6..........................................................0.5 ㎎Vitamin B 6 ... ........... 0.5 ㎎

비타민 B12.........................................................0.2 ㎍Vitamin B 12 ... .......... 0.2 ㎍

비타민 C.......................................10 ㎎Vitamin C ......................................... 10 mg

비오틴.........................................10 ㎍Biotin ......................................... 10 μg

니코틴산아미드.................................1.7 ㎎Nicotinic Acid Amide ... 1.7 mg

엽산...........................................50 ㎍Folic acid ......................................... 50 ㎍

판토텐산 칼슘.................................0.5 ㎎Calcium Pantothenate ......... 0.5 mg

무기질 혼합물.................................적 량Mineral mixture ..................

황산제1철.....................................1.75 ㎎Ferrous Sulfate ........................ 1.75 mg

산화아연......................................0.82 ㎎Zinc Oxide ......................................... 0.82 mg

탄산마그네슘..................................25.3 ㎎Magnesium Carbonate ......................................... 25.3 mg

제1인산칼륨....................................15 ㎎Potassium monophosphate ......................................... 15 mg

제2인산칼슘....................................55 ㎎Dicalcium Phosphate Diluent ... 55 mg

구연산칼륨.....................................90 ㎎Potassium Citrate ............... 90 mg

탄산칼슘.......................................100 ㎎Calcium Carbonate ... 100 mg

염화마그네슘..................................24.8 ㎎Magnesium Chloride ......................................... 24.8 mg

상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above-mentioned vitamin and mineral mixtures is mixed with a component suitable for a health food in a preferred embodiment, the compounding ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional health food manufacturing method. The granules may be prepared and used for preparing a health food composition according to a conventional method.

제제예Formulation example 2. 건강 음료의 제조 2. Manufacture of health drinks

실시예 2의 기능성 조성물..................1000 ㎎Functional composition of Example 2 .. 1000 mg

구연산....................................1000 ㎎Citric Acid ......................................... 1000 mg

올리고당...................................100 gOligosaccharide ......................... 100 g

매실농축액...................................2 gPlum concentrate ........................... 2 g

타우린.......................................1 gTaurine ......................................... 1 g

정제수를 가하여 전체......................900 ㎖Purified water is added to the whole ..... 900 ml

통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 ℓ 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. After mixing the above components in accordance with the conventional healthy beverage manufacturing method, and stirred and heated at 85 ℃ for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed sterilization and refrigerated Used to prepare the healthy beverage composition of the invention.

상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용 용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다. Although the composition ratio is a composition suitable for a preferred beverage in a preferred embodiment, the composition ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, use purpose.

본 발명에 따른 알로에베라겔 추출물, 에피갈로카테킨갈레이트(EGCG), 솔잎 추출물, 구아바잎 추출물, 비타민 C 및 비타민 B2로 이루어진 군으로부터 선택된 조합을 주성분으로 하고, 밀크티슬 추출물, 인진쑥 추출물, 운지버섯 추출물을 부가성분으로 포함하는 숙취 예방 및 개선용 기능성 조성물은 숙취해소에 뛰어난 효과를 나타내므로, 이를 유효성분으로 함유하는 식품, 식품첨가제 또는 건강기능식품으로 제품화되어 현대인의 음주 후 숙취 예방 및 개선에 유용하고 간편하게 이용될 수 있다. Aloe vera gel extract, epigallocatechin gallate (EGCG), pine needle extract, guava leaf extract, vitamin C and vitamin B 2 according to the present invention as a main ingredient, a combination of milk teal extract, jinjin mugwort extract, fingering Functional composition for preventing and improving hangover containing mushroom extract as an additional ingredient shows excellent effect on relieving hangover, and is commercialized as a food, food additive or health functional food containing it as an active ingredient to prevent and improve hangover after drinking It can be useful and convenient to use.

Claims (12)

알로에베라겔 추출물 20 - 40 중량 %, 에피갈로카테킨갈레이트(EGCG) 1 - 10 중량 %, 솔잎추출물 10 - 30 중량 %, 구아바잎 추출물 5 - 20 중량 %, 비타민C 0.5 - 5 중량 %, 비타민 B2 0.5 - 5 중량 %, 밀크티슬 추출물 5 - 20 중량 %, 인진쑥 추출물 1 - 10 중량 % 및 운지버섯 추출물 1 - 15 중량 %을 함유하는 숙취 예방 및 개선용 조성물.Aloe vera gel extract 20-40 wt%, epigallocatechin gallate (EGCG) 1-10 wt%, pine needle extract 10-30 wt%, guava leaf extract 5-20 wt%, vitamin C 0.5-5 wt%, vitamin B 2 0.5-5% by weight, milk thistle extract 5-20% by weight, 1 ~ 10% by weight of jinjin Mugwort extract and 1-15% by weight fingerling mushroom extract composition for preventing and improving hangover. 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete
KR1020050086889A 2005-09-16 2005-09-16 Functional composition for the prevention and improvement of hangover KR100690071B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020050086889A KR100690071B1 (en) 2005-09-16 2005-09-16 Functional composition for the prevention and improvement of hangover

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050086889A KR100690071B1 (en) 2005-09-16 2005-09-16 Functional composition for the prevention and improvement of hangover

Publications (1)

Publication Number Publication Date
KR100690071B1 true KR100690071B1 (en) 2007-03-08

Family

ID=38102497

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020050086889A KR100690071B1 (en) 2005-09-16 2005-09-16 Functional composition for the prevention and improvement of hangover

Country Status (1)

Country Link
KR (1) KR100690071B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101093998B1 (en) * 2009-03-26 2011-12-15 주식회사 벤스랩 Functional composition for the prevention of hangover and improving liver function
KR20180134481A (en) * 2017-06-09 2018-12-19 동부생약 영농조합법인 Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016779A (en) * 1994-11-14 1996-06-17 강성훈 Health mixed drink composition
JPH08169831A (en) * 1994-12-16 1996-07-02 Itouen:Kk Agent for promoting metabolism of alcohol in body and its production
KR20010036048A (en) * 1999-10-05 2001-05-07 천경호 Beverage composition for protection drunkage
KR20050035003A (en) * 2003-10-11 2005-04-15 주식회사 벤스랩 Functional composition for the prevention and improvement of smoking abuses and hangover

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016779A (en) * 1994-11-14 1996-06-17 강성훈 Health mixed drink composition
JPH08169831A (en) * 1994-12-16 1996-07-02 Itouen:Kk Agent for promoting metabolism of alcohol in body and its production
KR20010036048A (en) * 1999-10-05 2001-05-07 천경호 Beverage composition for protection drunkage
KR20050035003A (en) * 2003-10-11 2005-04-15 주식회사 벤스랩 Functional composition for the prevention and improvement of smoking abuses and hangover

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101093998B1 (en) * 2009-03-26 2011-12-15 주식회사 벤스랩 Functional composition for the prevention of hangover and improving liver function
KR20180134481A (en) * 2017-06-09 2018-12-19 동부생약 영농조합법인 Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology
KR101993709B1 (en) 2017-06-09 2019-06-26 동부생약 영농조합법인 Method for producing mixed extract of Dendropanax morbifera, Hovenia dulcis, Coriolus versicolor, Artemisia capillaris and Oenanthe javanica using response surface methodology

Similar Documents

Publication Publication Date Title
US8084061B2 (en) Body fat-reducing agent
JP2006188486A (en) Body fat accumulation-inhibiting or reducing agent
KR102020586B1 (en) Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof
KR102448542B1 (en) Composition for relieving menopausal symptom
KR101093998B1 (en) Functional composition for the prevention of hangover and improving liver function
KR20100128941A (en) Functional composition for the prevention and improvement of hangover, and food and food additive having the same
KR101565964B1 (en) Composition Comprising Water Extracts from Pleurotus eryngii var. ferulea (Pf.). for Treating or Preventing hyperlipidemia
KR100690071B1 (en) Functional composition for the prevention and improvement of hangover
KR100768830B1 (en) Extract of echinosophora koreensis removing hangover and having anti-oxidant activity
KR102437419B1 (en) Composition for removing hangover
KR102366919B1 (en) Functional health food composition for inhibiting muscle reduction comprising a mixed extract of mulberry twig, Eucommia bark, Acanthopanax, and black bean
KR101210748B1 (en) Composition comprising the extract of Acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome
KR100570959B1 (en) Functional Food Composition showing Anti-allergic rhinitis, Anti-atopic dermatitis and Anti-chronic asthma activity
KR100510253B1 (en) Functional Food Composition having Anti-oxidative, Anti-arthritic and Anti-dementia Activity
KR100872310B1 (en) Functional composition for the cotinene metabolism improvement which is caused by with smoking and hangover removal, foods and food additive containing the same
KR101636608B1 (en) Composition for antioxidation comprising the seed extract of cornus officinalis
KR20170077980A (en) Antioxidant or anti-aging composition comprising extracts of fresh sprouts of Xanthium canadense Mill.
KR20150120741A (en) Composition for preventing or improving atopic dermatitis comprising mixture of persimmon peel, persimmon flesh, persimmon leaf and Diospyros lotus leaf as effective component
KR100551464B1 (en) Composition comprising an extract of Saururus chinensis BAILL. for preventing and treating diabetes mellitus
KR20190125616A (en) Method for producing inner beauty beverage using Chrysanthemum zawadskii and fermeted Rhus verniciflua
KR102275824B1 (en) The anti-diabetes composition containing extract mixture and manufaturing method thereof
KR102302047B1 (en) Composition for hepatoprotective and ameliorating hangover
WO2006033496A1 (en) Functional composition for the prevention and alleviation of hangover
KR20180006612A (en) Compositions for preventing or treating diabetes mellitus comprising extract of Aster koraiensis or fraction thereof
KR20220001315A (en) A composition comprising an extract of Thymus quinquecostatus Celak for treating and preventing hangover

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130226

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20140226

Year of fee payment: 8

FPAY Annual fee payment

Payment date: 20150223

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20160224

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20170221

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20190131

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20200226

Year of fee payment: 14